PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 172 filers reported holding PDL BIOPHARMA INC in Q2 2017. The put-call ratio across all filers is 0.46 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $32,000 | +45.5% | 10,000 | 0.0% | 0.00% | +50.0% |
| Q3 2019 | $22,000 | -29.0% | 10,000 | 0.0% | 0.00% | -33.3% |
| Q2 2019 | $31,000 | -16.2% | 10,000 | 0.0% | 0.00% | -25.0% |
| Q1 2019 | $37,000 | +12.1% | 10,000 | -13.0% | 0.00% | 0.0% |
| Q4 2018 | $33,000 | +10.0% | 11,500 | 0.0% | 0.00% | +33.3% |
| Q3 2018 | $30,000 | +11.1% | 11,500 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $27,000 | -20.6% | 11,500 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $34,000 | +6.2% | 11,500 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $32,000 | -17.9% | 11,500 | 0.0% | 0.00% | -25.0% |
| Q3 2017 | $39,000 | +39.3% | 11,500 | 0.0% | 0.00% | +33.3% |
| Q2 2017 | $28,000 | +7.7% | 11,500 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $26,000 | – | 11,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nine Chapters Capital Management LLC | 119,700 | $254,000 | 0.43% |
| GSA CAPITAL PARTNERS LLP | 1,587,756 | $3,366,000 | 0.20% |
| AMERICAFIRST CAPITAL MANAGEMENT, LLC | 60,901 | $129,110,000 | 0.14% |
| Acrospire Investment Management LLC | 129,480 | $274,000 | 0.11% |
| SECOR Capital Advisors, LP | 410,323 | $870,000 | 0.11% |
| RBF Capital, LLC | 251,421 | $540,000 | 0.08% |
| Park West Asset Management LLC | 400,000 | $848,000 | 0.07% |
| MACKENZIE FINANCIAL CORP | 4,687,825 | $9,938,000 | 0.06% |
| CIGNA INVESTMENTS INC /NEW | 261,533 | $554,000,000 | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 5,503,285 | $11,665,000 | 0.06% |